High concentrations of S100 proteins (both S100A8/A9 and S100A12) are measured in patients with sJIA and therefore these molecules were proposed to be biomarkers (188–195). This evidence concerns the gene S100A8 and systemic-onset juvenile idiopathic arthritis.